Ustekinumab Dawns: Surveying The Biosimilar Landscape For IBD

Who’s Doing What In The IBD Space After IL-12/IL-23 Competition Opens Up

 
• By Dean Rudge
  
Dawn-new-era
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products